Vaccine Progress, Stock Prices, and the Value of Ending the Pandemic

Working Paper: CEPR ID: DP18025

Authors: Viral Acharya; Timothy Johnson; Suresh Sundaresan; Steven Zheng

Abstract: No abstract available

Keywords: COVID-19; Stock Prices; Welfare Costs; Vaccine News

JEL Codes: D6; D8; E21; E32; Q54


Causal Claims Network Graph

Edges that are evidenced by causal inference methods are in orange, and the rest are in light blue.


Causal Claims

CauseEffect
Vaccine deployment expectations (F17)Stock market valuations (G19)
Reduction in expected time to vaccine deployment by one year (C69)Aggregate stock market return (G17)
Changes in the vaccine progress indicator (VPI) (O33)Stock market returns (G17)
Stock market response to duration news (G14)Welfare implications of state transitions (D69)

Back to index